Calculation of binding affinities of HIV-1 RT and beta-secretase inhibitors using the linear interaction energy method with explicit and continuum solvation approaches.
The linear interaction energy (LIE) approach has been applied to estimate the binding free energies of representative sets of HIV-1 RT and beta-Secretase inhibitors, using both molecular dynamics (MD) and tethered energy minimization sampling protocols with the OPLS-AA potential, using a range of solvation methodologies. Generalized Born (GB), 'shell' and periodic boundary condition (PBC) solvation were used, the latter with reaction field (RF) electrostatics. Poisson-Boltzmann (PB) and GB continuum electrostatics schemes were applied to the simulation trajectories for each solvation type to estimate the electrostatic ligand-water interaction energy in both the free and bound states. Reasonable agreement of the LIE predictions was obtained with respect to experimental binding free energy estimates for both systems: for instance, 'PB' fits on MD trajectories carried out with PBC solvation and RF electrostatics led to models with standard errors of 1.11 and 1.03 kcal mol(-1) and coefficients of determination, r (2) of 0.76 and 0.75 for the HIV-1 RT and beta-Secretase sets. However, it was also found that results from MD sampling using PBC solvation provided only slightly better fits than from simulations using shell or Born solvation or tethered energy minimization sampling.
English
Niall J
NJ
Chemical Computing Group, St. John's Innovation Centre, Cambridge, UK. niall.english@ucd.ie
D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors* / Q000737:chemistry; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D003198:Computer Simulation; D015195:Drug Design; D054303:HIV Reverse Transcriptase / Q000737:chemistry*; D008024:Ligands; D008956:Models, Chemical; D011485:Protein Binding; D018894:Reverse Transcriptase Inhibitors / Q000737:chemistry*; D012997:Solvents; D055672:Static Electricity; D013816:Thermodynamics; D013997:Time Factors
D008024:Ligands; D018894:Reverse Transcriptase Inhibitors; D012997:Solvents; D054303:HIV Reverse Transcriptase; D053829:Amyloid Precursor Protein Secretases
J Med Chem. 2001 Oct 11;44(21):3417-23
11585447
Protein Eng. 1995 Nov;8(11):1137-44
8819979
J Med Chem. 1996 Apr 12;39(8):1589-600
8648598
Protein Eng. 1994 Mar;7(3):385-91
8177887
J Comput Aided Mol Des. 1998 Jan;12(1):27-35
9570087
J Chem Phys. 2006 Aug 28;125(8):084901
16965051
Proteins. 2004 Nov 15;57(3):493-503
15382241
J Med Chem. 1999 Dec 16;42(25):5142-52
10602699
Comb Chem High Throughput Screen. 2001 Dec;4(8):613-26
11812258
J Med Chem. 1998 Dec 17;41(26):5272-86
9857095
J Med Chem. 1995 Jul 21;38(15):2860-5
7636846
J Org Chem. 2001 May 4;66(9):3021-6
11325266
J Med Chem. 2001 Aug 30;44(18):2865-8
11520194
Proteins. 2000 Jun 1;39(4):393-407
10813821
J Chem Theory Comput. 2006 Jan;2(1):128-39
26626387
J Med Chem. 1991 Jan;34(1):349-57
1992136
J Med Chem. 1997 May 9;40(10 ):1539-49
9154975
Biochemistry. 2002 Sep 10;41(36):10963-7
12206667
Science. 2000 Oct 6;290(5489):150-3
11021803
J Comput Aided Mol Des. 1998 Mar;12(2):119-31
9690172
J Med Chem. 2003 May 22;46(11):2074-82
12747779
Bioorg Med Chem. 1999 May;7(5):851-60
10400338
J Med Chem. 1992 Dec 11;35(25):4713-9
1469700
J Cell Mol Med. 2004 Oct-Dec;8(4):551-62
15601584
J Phys Chem B. 2006 Jun 22;110(24):12034-41
16800513
Proteins. 1999 Feb 15;34(3):395-402
10024025
Proteins. 1992 Jul;13(3):206-22
1603810
J Med Chem. 2001 Mar 29;44(7):1035-42
11297450
Protein Sci. 2004 Apr;13(4):1056-70
15044735
Annu Rev Biophys Biophys Chem. 1989;18:431-92
2660832